Psychiatry and Neurology, Neurology · Los Angeles, CA
NPI
1407958234
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6200 Wilshire Blvd, Suite 1708
Los Angeles, CA, 90048
Phone (323) 939-0008
Groups this clinician bills Medicare through
Medicare paid, 2024
$53K
315 services
Medicare patients, 2024
103
Average age 65
Drug cost, 2024
$745K
2,174 prescriptions
Company payments, 2025
$2,482
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raafat Iskander was code 99215 (office e&m - established), 182 times for 81 patients. In total Raafat Iskander billed 315 services in 5 codes, and Medicare paid $53K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 182 | 81 | $113.84 | $21K |
| 95812 Neurologic | Office | 88 | 47 | $287.18 | $25K |
| 99205 Office E&M - New | Office | 41 | 41 | $152.64 | $6,258 |
By year: 2022 $27K for 225 services; 2023 $32K for 231 services; 2024 $53K for 315 services.
Medicare prescription drug claims, 2024
In 2024, the drug Raafat Iskander prescribed most often to Medicare patients was Fluoxetine Hcl, with 168 prescriptions and refills. In total Raafat Iskander wrote 2,174 Medicare prescriptions that cost $745K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluoxetine Hcl Generic | 168 | 174 | 27 | $233 |
| Lacosamide Generic | 155 | 165 | 20 | $7,349 |
| Levetiracetam Generic | 153 | 188 | 23 | $3,488 |
| Clobazam Generic | 146 | 149 | 17 | $19K |
| Memantine Hcl Generic | 136 | 156 | 30 | $1,642 |
| Propranolol Hcl Er Propranolol Hcl | 130 | 162 | 27 | $1,685 |
| Topiramate Generic | 100 | 122 | 22 | $853 |
| Trazodone Hcl Generic | 94 | 98 | 18 | $245 |
| Aptiom Eslicarbazepine Acetate | 91 | 91 | Under 11 | $140K |
| Clopidogrel Clopidogrel Bisulfate | 80 | 144 | 26 | $625 |
| Clonazepam Generic | 75 | 82 | 13 | $168 |
| Divalproex Sodium Generic | 63 | 63 | Under 11 | $1,498 |
| Fycompa Perampanel | 62 | 62 | Under 11 | $60K |
| Lamotrigine Odt Lamotrigine | 60 | 60 | Under 11 | $20K |
| Donepezil Hcl Generic | 51 | 67 | Under 11 | $297 |
Brand drugs: - claims; generic drugs: 1,903 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raafat Iskander $2,482 ($2,482 in general payments such as food, travel and fees) from 16 companies. The largest payer was UCB, Inc. with $697.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 17 | $697 |
| SK Life Science, Inc. | 12 | $531 |
| Neurelis, Inc. | 7 | $254 |
| Eisai Inc. 4523.T | 2 | $229 |
| Biogen, Inc. BIIB | 10 | $161 |
| Harmony Biosciences LLC HRMY | 1 | $123 |
| EMD Serono, Inc. MRK.DE | 1 | $121 |
| Jazz Pharmaceuticals Inc. JAZZ | 3 | $80.41 |
| Boston Scientific Corporation BSX | 2 | $73.05 |
| LivaNova USA, Inc. LIVN | 1 | $48.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.